| | COMPOUND: C07020 | |
Entry |
|
Name |
|
Formula |
C15H22O3
|
Exact mass |
250.1569
|
Mol weight |
250.3334
|
Structure |
|
Remark |
|
Pathway |
map05207 | Chemical carcinogenesis - receptor activation |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C10 LIPID MODIFYING AGENTS
C10A LIPID MODIFYING AGENTS, PLAIN
C10AB Fibrates
C10AB04 Gemfibrozil
D00334 Gemfibrozil (JAN/USP/INN) <US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Dyslipidemics, Fibric Acid Derivatives
Gemfibrozil
D00334 Gemfibrozil (JAN/USP/INN)
Drug groups [BR:br08330]
Hypolipidemic agent
DG01946 Hypolipidemic agent
DG01733 PPAR alpha agonist
DG01547 Fibrate
D00334 Gemfibrozil
Metabolizing enzyme inhibitor
DG01641 CYP2C8 inhibitor
D00334 Gemfibrozil
Transporter inhibitor
DG02865 SLCO1B1 inhibitor
D00334 Gemfibrozil
Drug classes [BR:br08332]
Cardiovascular agent
DG01946 Hypolipidemic agent
D00334 Gemfibrozil
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C1 (PPARA)
D00334 Gemfibrozil (JAN/USP/INN) <US>
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00334
Drug transporters
D00334
|
Other DBs |
|
KCF data |
ATOM 18
1 C8x C 18.7600 -21.1400
2 C8x C 18.7600 -22.5400
3 C8y C 19.9500 -23.2400
4 C8y C 21.1400 -22.5400
5 C8x C 21.1400 -21.1400
6 C8y C 19.9500 -20.4400
7 C1a C 19.9500 -19.0400
8 C1a C 19.9500 -24.6400
9 O2a O 22.4000 -23.3100
10 C1b C 23.5900 -22.6100
11 C1b C 24.7800 -23.2400
12 C1b C 25.9700 -22.6100
13 C1d C 27.1600 -23.2400
14 C6a C 28.4200 -22.5400
15 O6a O 29.6100 -23.2400
16 O6a O 28.4200 -21.1400
17 C1a C 26.4600 -24.5000
18 C1a C 27.9300 -24.4300
BOND 18
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 6 7 1
8 3 8 1
9 4 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 14 16 2
17 13 17 1
18 13 18 1
|
|
» Japanese version
|
|